These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 33763698)

  • 1. YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner.
    Feng M; Xie X; Han G; Zhang T; Li Y; Li Y; Yin R; Wang Q; Zhang T; Wang P; Hu J; Cheng Y; Gao Z; Wang J; Chang J; Cui M; Gao K; Chai J; Liu W; Guo C; Li S; Liu L; Zhou F; Chen J; Zhang H
    Blood; 2021 Jul; 138(1):71-85. PubMed ID: 33763698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YBX1 mediates translation of oncogenic transcripts to control cell competition in AML.
    Perner F; Schnoeder TM; Xiong Y; Jayavelu AK; Mashamba N; Santamaria NT; Huber N; Todorova K; Hatton C; Perner B; Eifert T; Murphy C; Hartmann M; Hoell JI; Schröder N; Brandt S; Hochhaus A; Mertens PR; Mann M; Armstrong SA; Mandinova A; Heidel FH
    Leukemia; 2022 Feb; 36(2):426-437. PubMed ID: 34465866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability.
    Zhang N; Shen Y; Li H; Chen Y; Zhang P; Lou S; Deng J
    Exp Mol Med; 2022 Feb; 54(2):194-205. PubMed ID: 35217832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m
    Weng H; Huang H; Wu H; Qin X; Zhao BS; Dong L; Shi H; Skibbe J; Shen C; Hu C; Sheng Y; Wang Y; Wunderlich M; Zhang B; Dore LC; Su R; Deng X; Ferchen K; Li C; Sun M; Lu Z; Jiang X; Marcucci G; Mulloy JC; Yang J; Qian Z; Wei M; He C; Chen J
    Cell Stem Cell; 2018 Feb; 22(2):191-205.e9. PubMed ID: 29290617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YBX1 regulates the survival of chronic myeloid leukemia stem cells by modulating m
    Chai J; Wang Q; Qiu Q; Han G; Chen Y; Li W; Zhang H
    Cell Oncol (Dordr); 2023 Apr; 46(2):451-464. PubMed ID: 36512307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YBX1 expression and function in early hematopoiesis and leukemic cells.
    Bhullar J; Sollars VE
    Immunogenetics; 2011 Jun; 63(6):337-50. PubMed ID: 21369783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YBX1 as an oncogenic factor in T-cell acute lymphoblastic leukemia.
    Li H; Zhang D; Fu Q; Wang S; Wang Z; Zhang X; Chen X; Zhu X; An N; Chen Y; Zhou L; Lu D; Zhao N
    Blood Adv; 2023 Sep; 7(17):4874-4885. PubMed ID: 37339496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N
    Cheng Y; Xie W; Pickering BF; Chu KL; Savino AM; Yang X; Luo H; Nguyen DT; Mo S; Barin E; Velleca A; Rohwetter TM; Patel DJ; Jaffrey SR; Kharas MG
    Cancer Cell; 2021 Jul; 39(7):958-972.e8. PubMed ID: 34048709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functions of N6-methyladenosine (m6A) RNA modifications in acute myeloid leukemia.
    Fang Z; Ding H; Han J; Fu L; Jin J; Feng W
    J Leukoc Biol; 2024 Oct; 116(4):662-671. PubMed ID: 38721720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LNCAROD is stabilized by m6A methylation and promotes cancer progression via forming a ternary complex with HSPA1A and YBX1 in head and neck squamous cell carcinoma.
    Ban Y; Tan P; Cai J; Li J; Hu M; Zhou Y; Mei Y; Tan Y; Li X; Zeng Z; Xiong W; Li G; Li X; Yi M; Xiang B
    Mol Oncol; 2020 Jun; 14(6):1282-1296. PubMed ID: 32216017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA-binding proteins as drivers of AML and novel therapeutic targets.
    Qin T; Cheng Y; Wang X
    Leuk Lymphoma; 2022 May; 63(5):1045-1057. PubMed ID: 35075986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TTC5 is required to prevent apoptosis of acute myeloid leukemia stem cells.
    Lynch JT; Somerville TD; Spencer GJ; Huang X; Somervaille TC
    Cell Death Dis; 2013 Apr; 4(4):e573. PubMed ID: 23559008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Methyltransferase-like 3 Promotes the Proliferation of Acute Myeloid Leukemia Cells by Regulating N6-methyladenosine Levels of MYC].
    Wang XS; He JR; Yu S; Yu J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Jun; 40(3):308-314. PubMed ID: 29978784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization in Acute Myeloid Leukemia.
    Du A; Wu X; Gao Y; Jiang B; Wang J; Zhang P; Zhao Q
    Front Immunol; 2021; 12():789914. PubMed ID: 34887874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. METTL14-mediated N6-methyladenosine modification of TCP1 mRNA promotes acute myeloid leukemia progression.
    Zhang M; Xie Z; Tan Y; Wu Y; Wang M; Zhang P; Yuan Y; Li J
    Cell Signal; 2024 Oct; 122():111304. PubMed ID: 39033992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N6-methyladenosine-modified SENP1, identified by IGF2BP3, is a novel molecular marker in acute myeloid leukemia and aggravates progression by activating AKT signal via de-SUMOylating HDAC2.
    Wen D; Xiao H; Gao Y; Zeng H; Deng J
    Mol Cancer; 2024 May; 23(1):116. PubMed ID: 38822351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KMT2D-mediated H3K4me1 recruits YBX1 to facilitate triple-negative breast cancer progression through epigenetic activation of c-Myc.
    Yao B; Xing M; Zeng X; Zhang M; Zheng Q; Wang Z; Peng B; Qu S; Li L; Jin Y; Li H; Yuan H; Zhao Q; Ma C
    Clin Transl Med; 2024 Jul; 14(7):e1753. PubMed ID: 38967349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic inhibition of GAS6-AS1/YBX1/MYC axis suppresses cell propagation and disease progression of acute myeloid leukemia.
    Zhou H; Liu W; Zhou Y; Hong Z; Ni J; Zhang X; Li Z; Li M; He W; Zhang D; Chen X; Zhu J
    J Exp Clin Cancer Res; 2021 Nov; 40(1):353. PubMed ID: 34753494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N6-methyladenosine RNA modifications: a potential therapeutic target for AML.
    Hu R; Liao P; Xu B; Qiu Y; Zhang H; Li Y
    Ann Hematol; 2024 Aug; 103(8):2601-2612. PubMed ID: 37548690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The N6-methyladenosine RNA modification in acute myeloid leukemia.
    Yankova E; Aspris D; Tzelepis K
    Curr Opin Hematol; 2021 Mar; 28(2):80-85. PubMed ID: 33337619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.